Purchase Order 75N93023P00974
Award Date 7/20/23
Potential Completion Date 8/31/23
Potential Value $14K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $35,187.48 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for an annual service agreement for its LSR Fortessa instrument and FACS flow cytometry system. The period of performance is from September 20, 2023 through September 19, 2024 and all work will take place in Bethesda, Maryland. No set...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a Firm Fixed Price purchase order valued at $15,976.71 on May 10, 2025, by the National Institute of Allergy and Infectious Diseases (NIAID) to provide maintenance and service support for an LSR Fortessa flow cytometry system at the NIH facility in Bethesda, Maryland. This contract, which concludes on September 30, 2025, represents a component of the FY26 Unified Digital Operations (UDO) Initiative and was awarded...
- The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), awarded a $125,132.58 firm fixed-price purchase order to Becton, Dickinson and Company (BD) for a 12-month preventive maintenance service agreement covering three BD LSRFortessa flow cytometry instruments and a FACS Flow Supply System located at the NIH's LCIM facility in Bethesda, Maryland. The contract, which runs from May 25, 2025, to May 24, 2026, was awarded on an other...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,000 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for relocation and reinstallation services of a BD FACS Aria flow cytometer. BD Biosciences will perform the work as the prime contractor. The place of performance will be in Bethesda, Maryland and work must be completed between August 28,...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company, through its BD Biosciences division, for service contract work on laboratory equipment on April 1, 2023, with a ceiling value of $236,470.02. The order is firm fixed price with no set-aside applied. Performance takes place in North Bethesda, Maryland. The ultimate completion date is March 31, 2024.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Becton, Dickinson And Company (BD) a $104,434.80 firm fixed price purchase order for annual maintenance on a Facscelesta flow cytometer instrument, including a throughput sampler and sampler. The award date was July 22, 2019 and the completion date is September 28, 2024. No set-aside was used for this competition. BD is a global medical technology company that...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Becton, Dickinson And Company (BD), a global medical technology company, a firm fixed-price purchase order to provide 3 annual maintenance and service agreements for LSRFORTESSA flow cytometry systems. The total potential value of the contract is $115,539.48, with a completion date of May 24, 2024. This award is not associated with any set-aside designation. BD,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Becton, Dickinson And Company (BD), a global medical technology manufacturer, for a service agreement to provide a Facsaria Fusion SORP flow cytometry system with Rhapsody and OBIS laser accessories. The award has a potential value of $163,080.00 and a completion date of January 4, 2024. This purchase order is not set aside...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,000 firm fixed price purchase order to Becton, Dickinson and Company for repair services for a flow cytometer instrument in support of its programs. BD Biosciences, a division of BD, will perform as the prime contractor to deliver maintenance and repair services for the flow cytometer located at the agency's facility in Bethesda, Maryland by the January...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $162,165.60 firm fixed-price purchase order to Becton, Dickinson and Company's BDB Division, operating as BD Biosciences, for maintenance and service on LSRFortessa X-20 SORP (Special Order Research Product) and laser systems. This contract represents Option Year 3 of an existing maintenance and service agreement, with performance extending through April 30, 2028. The award, issued May 1, 2023, follows a competitive...
The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences division) on July 20, 2023, for $13,567.50 to conduct pre-inspection for recertification and preparation of a forthcoming service agreement on a BD LSRFortessa flow cytometry system. No set-aside was used. Work is performed at Bethesda, Maryland. The order carries a firm fixed price and an ultimate completion date of August 31, 2023.
Generated 5/22/26, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($1k) | 5/20/26 | |
| Not listed | Not listed | $15.0k | 7/21/23 |